Genome expression profiling identifies host-directed antimicrobial drugs against respiratory infection by nontypable Haemophilus influenza.
Trabajo presentado en el XIII Congress of The European Meningoccocal Disease (EMGM), celebrado en Amsterdam del 14 al 17 de septiembre de 2015.
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | comunicación de congreso biblioteca |
| Published: |
2015-09
|
| Online Access: | http://hdl.handle.net/10261/142354 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| id |
dig-idab-es-10261-142354 |
|---|---|
| record_format |
koha |
| spelling |
dig-idab-es-10261-1423542017-06-08T09:00:47Z Genome expression profiling identifies host-directed antimicrobial drugs against respiratory infection by nontypable Haemophilus influenza. Garmendia, Juncal Euba, Begoña Moleres, Javier Segura, Víctor Viadas, Cristina Morey, Pau Moranta, David Leiva, José de-Torres, Juan Pablo Bengoechea, José Antonio Trabajo presentado en el XIII Congress of The European Meningoccocal Disease (EMGM), celebrado en Amsterdam del 14 al 17 de septiembre de 2015. [Introduction and Aim] Therapies being safe, effective and not vulnerable to develop resistance are highly desirable to counteract bacterial infections. Host-directed therapeutics is an alternative to conventional antibiotics which is based on perturbing host pathways subverted by pathogens during their life cycle by using host-directed drugs to counteract microbial infections. This study applied this concept to the identification of host-directed target and drug candidates against respiratory infection by nontypable Haemophilus influenzae (NTHi), through the screening of cellular genes and pathways differentially expressed during airways epithelial infection by this pathogen. NTHi is an intracellular facultative opportunistic pathogen, which is an important cause of exacerbation associated to the progression of chronic obstructive pulmonary disease (COPD). Based on the proposed relationship between NTHi intracellular location and persist infection, the antimicrobial potential of a panel of drugs perturbing host pathways used by NTHi to enter epithelial cells was investigated. [Methods] We screened for host genes differentially expressed upon infection by the clinical isolate NTHi375 by analyzing human type II pneumocyte A549 cells whole genome expression profiling, and identified a panel of host target candidates which were pharmacologically modulated. Interfering drugs were tested for their bactericidal effect, cytotoxicity, effect on the interplay NTHi-epithelial cell (adhesion, invasion and inflammatory response on respiratory cells), and effect on NTHi respiratory infection in vivo, by assessing lung bacterial loads in a murine intranasal infection model. [Results] he sirtuin-1 activator resveratrol showed a dose dependent bactericidal effect against NTHi; the non-bactericidal phosphodiesterase 4 (PDE4) inhibitor rolipram showed therapeutic efficacy by lowering NTHi375 counts intracellularly and in the lungs of infected mice. [Conclusions] PDE4 inhibition is currently prescribed in COPD; resveratrol is a natural geroprotector attractive for COPD treatment by preventing lung aging. This work provides evidence for the antimicrobial potential of rolipram and resveratrol against NTHi respiratory infection. Peer Reviewed 2017-01-11T08:01:24Z 2017-01-11T08:01:24Z 2015-09 2017-01-11T08:01:24Z comunicación de congreso http://purl.org/coar/resource_type/c_5794 XIII Congress of The European Meningoccocal Disease (2015) http://hdl.handle.net/10261/142354 Sí none |
| institution |
IDAB ES |
| collection |
DSpace |
| country |
España |
| countrycode |
ES |
| component |
Bibliográfico |
| access |
En linea |
| databasecode |
dig-idab-es |
| tag |
biblioteca |
| region |
Europa del Sur |
| libraryname |
Biblioteca del IDAB España |
| description |
Trabajo presentado en el XIII Congress of The European Meningoccocal Disease (EMGM), celebrado en Amsterdam del 14 al 17 de septiembre de 2015. |
| format |
comunicación de congreso |
| author |
Garmendia, Juncal Euba, Begoña Moleres, Javier Segura, Víctor Viadas, Cristina Morey, Pau Moranta, David Leiva, José de-Torres, Juan Pablo Bengoechea, José Antonio |
| spellingShingle |
Garmendia, Juncal Euba, Begoña Moleres, Javier Segura, Víctor Viadas, Cristina Morey, Pau Moranta, David Leiva, José de-Torres, Juan Pablo Bengoechea, José Antonio Genome expression profiling identifies host-directed antimicrobial drugs against respiratory infection by nontypable Haemophilus influenza. |
| author_facet |
Garmendia, Juncal Euba, Begoña Moleres, Javier Segura, Víctor Viadas, Cristina Morey, Pau Moranta, David Leiva, José de-Torres, Juan Pablo Bengoechea, José Antonio |
| author_sort |
Garmendia, Juncal |
| title |
Genome expression profiling identifies host-directed antimicrobial drugs against respiratory infection by nontypable Haemophilus influenza. |
| title_short |
Genome expression profiling identifies host-directed antimicrobial drugs against respiratory infection by nontypable Haemophilus influenza. |
| title_full |
Genome expression profiling identifies host-directed antimicrobial drugs against respiratory infection by nontypable Haemophilus influenza. |
| title_fullStr |
Genome expression profiling identifies host-directed antimicrobial drugs against respiratory infection by nontypable Haemophilus influenza. |
| title_full_unstemmed |
Genome expression profiling identifies host-directed antimicrobial drugs against respiratory infection by nontypable Haemophilus influenza. |
| title_sort |
genome expression profiling identifies host-directed antimicrobial drugs against respiratory infection by nontypable haemophilus influenza. |
| publishDate |
2015-09 |
| url |
http://hdl.handle.net/10261/142354 |
| work_keys_str_mv |
AT garmendiajuncal genomeexpressionprofilingidentifieshostdirectedantimicrobialdrugsagainstrespiratoryinfectionbynontypablehaemophilusinfluenza AT eubabegona genomeexpressionprofilingidentifieshostdirectedantimicrobialdrugsagainstrespiratoryinfectionbynontypablehaemophilusinfluenza AT moleresjavier genomeexpressionprofilingidentifieshostdirectedantimicrobialdrugsagainstrespiratoryinfectionbynontypablehaemophilusinfluenza AT seguravictor genomeexpressionprofilingidentifieshostdirectedantimicrobialdrugsagainstrespiratoryinfectionbynontypablehaemophilusinfluenza AT viadascristina genomeexpressionprofilingidentifieshostdirectedantimicrobialdrugsagainstrespiratoryinfectionbynontypablehaemophilusinfluenza AT moreypau genomeexpressionprofilingidentifieshostdirectedantimicrobialdrugsagainstrespiratoryinfectionbynontypablehaemophilusinfluenza AT morantadavid genomeexpressionprofilingidentifieshostdirectedantimicrobialdrugsagainstrespiratoryinfectionbynontypablehaemophilusinfluenza AT leivajose genomeexpressionprofilingidentifieshostdirectedantimicrobialdrugsagainstrespiratoryinfectionbynontypablehaemophilusinfluenza AT detorresjuanpablo genomeexpressionprofilingidentifieshostdirectedantimicrobialdrugsagainstrespiratoryinfectionbynontypablehaemophilusinfluenza AT bengoecheajoseantonio genomeexpressionprofilingidentifieshostdirectedantimicrobialdrugsagainstrespiratoryinfectionbynontypablehaemophilusinfluenza |
| _version_ |
1777663482186956800 |